Interdependence of macrophages and T-cells in partial spontaneous regression of intrahepatic cholangiocarcinoma in a cow: a histopathologic perspective
Comparative Clinical Pathology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 5, 2025
Language: Английский
Research progress of T cells in cholangiocarcinoma
Zhiming Wang,
No information about this author
Yunyan Dai,
No information about this author
Yunpeng Zhou
No information about this author
et al.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: Feb. 25, 2025
Cholangiocarcinoma
(CCA),
a
malignant
tumor,
is
typically
challenging
to
detect
early
and
often
results
in
poor
prognosis.
In
recent
years,
research
interest
has
grown
the
potential
application
of
immunotherapy
for
CCA
treatment.
T
cells,
as
crucial
component
immune
system,
play
significant
role
surveillance
therapy
cholangiocarcinoma.
This
article
provides
review
advancements
concerning
cells
cholangiocarcinoma
patients,
including
their
distribution,
functional
status,
correlation
with
patient
prognosis
within
tumor
microenvironment.
It
further
discusses
applications
challenges
strategies
targeting
treatment
anticipates
future
directions.
A
more
profound
understanding
cells'
can
guide
development
clinical
strategies,
thereby
enhancing
survival
rates
quality
life.
Finally,
we
explored
risks
side
effects
T-cell
Language: Английский
Research hotspots and trends in immunotherapy for cholangiocarcinoma: a bibliometric analysis (2014-2023)
Xi-lin Qu,
No information about this author
Qian Wang,
No information about this author
Fengfeng Zhu
No information about this author
et al.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Nov. 26, 2024
Cholangiocarcinoma
(CCA)
is
a
malignant
tumor
of
the
gastrointestinal
tract
with
poor
prognosis.
Immunotherapy
plays
an
important
role
in
treatment
CCA.
This
study
aimed
to
investigate
research
hotspots
and
trends
immunotherapy
for
Language: Английский
New Relevant Evidence in Cholangiocarcinoma Biology and Characterization
Cancers,
Journal Year:
2024,
Volume and Issue:
16(24), P. 4239 - 4239
Published: Dec. 19, 2024
Among
solid
tumors,
cholangiocarcinoma
(CCA)
emerges
as
one
of
the
most
difficult
to
eradicate.
The
silent
and
asymptomatic
nature
this
tumor,
particularly
in
its
early
stages,
well
high
heterogeneity
at
genomic,
epigenetic,
molecular
levels
delay
diagnosis,
significantly
compromising
efficacy
current
therapeutic
options
thus
contributing
a
dismal
prognosis.
Extensive
research
has
been
conducted
on
pathobiology
CCA,
recent
advances
have
made
classification
characterization
new
targets.
Both
targeted
therapy
immunotherapy
emerged
effective
safe
strategies
for
various
types
cancers,
demonstrating
potential
benefits
advanced
CCA.
Furthermore,
deeper
comprehension
cellular
components
tumor
microenvironment
(TME)
opened
up
possibilities
innovative
treatment
methods.
This
review
discusses
evidence
biology
highlighting
novel
possible
druggable
Language: Английский